Related Experiment Videos
[Hyperhomocysteinemia in patients with dementia]
1I Kliniki Neurologicznej Instytutu Psychiatrii i Neurologii w Warszawie.
Neurologia I Neurochirurgia Polska
|January 30, 2004
Summary
Elevated homocysteine levels are linked to dementia, Alzheimer's disease, and vascular issues. Deficiencies in folic acid, vitamin B6, and vitamin B12 often contribute to high homocysteine, especially in the elderly.
Area of Science:
- Neuroscience
- Cardiovascular Science
- Metabolic Science
Context:
- Dementia, including Alzheimer's disease, is a growing public health concern.
- Vascular risk factors like hypertension and diabetes are also linked to Alzheimer's.
- Elevated homocysteine is increasingly recognized as a factor in both vascular disease and neurodegeneration.
Purpose:
- To explore the link between hyperhomocysteinemia and angiogenic brain damage.
- To understand the role of homocysteine in the pathogenesis of Alzheimer's disease.
- To investigate the mechanisms by which homocysteine contributes to vascular and cognitive decline.
Summary:
- Hyperhomocysteinemia, an excess of homocysteine, is associated with accelerated microangiopathic changes and endothelial damage.
- Homocysteine impacts nitrogen oxide (NO) levels, affecting vasodilation and potentially contributing to atherogenesis.
- Metabolic pathways for homocysteine involve B vitamins (B12, folic acid, B6), and deficiencies in these are common causes of elevated levels, particularly in the elderly.
Impact:
- Highlights homocysteine as a potential therapeutic target for dementia and vascular diseases.
- Emphasizes the importance of monitoring and correcting B vitamin deficiencies to mitigate neurological and vascular risks.
- Underscores the interplay between vascular health and cognitive function, suggesting a unified approach to prevention and treatment.